These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8245481)

  • 1. Analysis of glomeruli-eluted Gp330 autoantibodies and of Gp330 antigen of Heymann nephritis.
    Makker SP
    J Immunol; 1993 Dec; 151(11):6500-8. PubMed ID: 8245481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane.
    Kerjaschki D; Miettinen A; Farquhar MG
    J Exp Med; 1987 Jul; 166(1):109-28. PubMed ID: 2885390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope specificity of anti-gp330 autoantibodies determines the development of proteinuria in active Heymann nephritis.
    Van Leer EH; Ronco P; Verroust P; van der Wal AM; Hoedemaeker PJ; De Heer E
    Am J Pathol; 1993 Mar; 142(3):821-9. PubMed ID: 7681258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A possible ligand of serum origin for the kidney autoantigen of Heymann nephritis.
    Kanalas JJ; Makker SP
    J Immunol; 1988 Dec; 141(12):4152-7. PubMed ID: 3264306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats.
    Kerjaschki D; Farquhar MG
    J Exp Med; 1983 Feb; 157(2):667-86. PubMed ID: 6337231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of a 330-kDa glycoprotein from human kidney similar to the Heymann nephritis autoantigen (gp330).
    Kanalas JJ; Makker SP
    J Am Soc Nephrol; 1990 Nov; 1(5):792-8. PubMed ID: 2133428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning of a cDNA encoding a major pathogenic domain of the Heymann nephritis antigen gp330.
    Pietromonaco S; Kerjaschki D; Binder S; Ullrich R; Farquhar MG
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1811-5. PubMed ID: 2408041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Heymann nephritis with a gp330/megalin fusion protein.
    Raychowdhury R; Zheng G; Brown D; McCluskey RT
    Am J Pathol; 1996 May; 148(5):1613-23. PubMed ID: 8623929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of receptor-associated 39/45 kD protein in active Heymann nephritis.
    Huang J; Makker SP
    Kidney Int; 1995 Feb; 47(2):432-41. PubMed ID: 7723231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity and cross-reactive idiotypes of anti-gp330 autoantibodies in active Heymann nephritis.
    Specht Grijp-Glandorf RJ; De Heer E; Dekker-Nooren CC; Daha MR; Van Es LA
    Immunology; 1990 Jul; 70(3):290-5. PubMed ID: 1696240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with mycophenolate mofetil attenuates the development of Heymann nephritis.
    Luca ME; Paul LC; van Der Wal AM; Bruijn JA; de Heer E
    Exp Nephrol; 2000; 8(2):77-83. PubMed ID: 10729746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephritogenicity and immunocytochemical localization of the 70-kilodalton glycoprotein subunit (gp70) of Heymann antigen.
    Singh AK; Schwartz MM
    Clin Immunol Immunopathol; 1988 Jul; 48(1):61-77. PubMed ID: 3289803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel autoantibody to plasminogen and its characterization in Heymann nephritis.
    Makker SP
    Clin Immunol Immunopathol; 1994 Jul; 72(1):105-13. PubMed ID: 8020183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of two forms of GP330. Their role in Heymann nephritis.
    Bachinsky DR; Zheng G; Niles JL; McLaughlin M; Abbate M; Andres G; Brown D; McCluskey RT
    Am J Pathol; 1993 Aug; 143(2):598-611. PubMed ID: 8342605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of alterations in glomerular charge on deposition of cationic and anionic antibodies to fixed glomerular antigens in the rat.
    Adler S; Baker P; Pritzl P; Couser WG
    J Lab Clin Med; 1985 Jul; 106(1):1-11. PubMed ID: 3891891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive Heymann nephritis with acute and severe proteinuria induced by heterologous antibody against renal tubular brush border glycoprotein gp108.
    Natori Y; Hayakawa I; Shibata S
    Lab Invest; 1986 Jul; 55(1):63-70. PubMed ID: 3755192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the nephritogenic autoantibody of Heymann's nephritis on plasminogen-binding to gp330 and activation by urokinase.
    Kanalas JJ
    Biochim Biophys Acta; 1993 Nov; 1225(1):101-6. PubMed ID: 8241286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A major pathogenic antigen of Heymann nephritis is present exclusively in the renal proximal tubule brush border--studies with a monoclonal antibody against pronase-digested tubular antigen.
    Tsukada Y; Ono K; Maezawa A; Yano S; Naruse T
    Clin Exp Immunol; 1994 May; 96(2):303-10. PubMed ID: 8187338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.